Caffeine Withdrawal
8
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
12.5%
1 terminated out of 8 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Remote Guided Caffeine Reduction
A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products
The Acute Effects of Exercise and Caffeine on Working Memory During Acute Caffeine Deprivation
Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus
Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists
Influence of Caffeine Consumption on the Human Circadian System
The Effects of Caffeine Withdrawal on Migraine
Cognitive and Cerebral Blood Flow Effects of 2-week Caffeine Abstinence or Maintenance